Status:
COMPLETED
Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer Screening
Lead Sponsor:
University Hospital, Caen
Collaborating Sponsors:
National Cancer Institute, France
Ligue contre le cancer, France
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-74 years
Phase:
PHASE3
Brief Summary
Colorectal cancer screening by faecal occult blood test (FOBT) is a high public health priority. The interest of guaiac tests (G-FOBT) is limited by their poor sensitivity, while the superiority of I-...
Eligibility Criteria
Inclusion
- 50 to 74 years
- Informed consent signed
Exclusion
- Recent digestive symptoms
- Complete colonoscopy less than 5 years ago
- Personal history of colorectal cancer or colorectal adenoma or colonic disease requiring regular colonoscopy surveillance
- Familial history of colorectal cancer in a first degree next of kin before 65 years, or two cases in first degree next of kin.
- Severe extra-intestinal disease
- Screening ill-timed (ex. depression)
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
19797 Patients enrolled
Trial Details
Trial ID
NCT01251666
Start Date
June 1 2008
End Date
August 1 2012
Last Update
September 3 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
ADECA
Moulins, France, 03007
2
Adoc18 - Irsa
Saint-Doulchard, France, 18230